CTX-GLS

Yes, CTX-GLS 200mg Injection can cause infertility in both men and women. It may interfere with the normal menstrual cycle in women and may stop sperm production in men. If you are considering becoming parents after the treatment please discuss this with your doctor. Talk to your doctor about cryopreservation (freezing) of sperm or eggs prior to treatment because of the possibility of irreversible infertility due to therapy with CTX-GLS 200mg Injection.

No, there is no evidence that you need to avoid sun exposure while on CTX-GLS 200mg Injection. Skin and nail discoloration are reported rarely with CTX-GLS 200mg Injection.

Cancer medicines and radiation therapy can increase the risk of developing other cancers. These may not develop soon and may take a number of years after the completion of your treatment. The risk of developing cancer with CTX-GLS 200mg Injection is high in the urinary bladder. Other rare cancers that may occur with use of CTX-GLS 200mg Injection include Acute leukemia, Myelodysplastic syndrome, and cancer of the ureters.

Yes, CTX-GLS 200mg Injection is a chemotherapy medicine, it belongs to the class of alkylating agents. It works by killing cancer cells. It is also known as cytotoxic medicine.

Yes, CTX-GLS 200mg Injection can be used to treat nephrotic syndrome (a disease that is caused by damage to the kidneys) in children whose disease has not improved, has gotten worse, or has come back after taking other medications. Along with that, it can be used in children who experienced intolerable side effects with other medications. However, in adults, the safety and effectiveness of CTX-GLS 200mg Injection for nephrotic syndrome has not been established.

Yes, CTX-GLS 200mg Injection may cause weight loss because of reduced appetite. This reduction in weight could be due to underlying cancer. Consult your doctor, if weight loss is worrying you.